Selective Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibition by the SCH772984 Compound Attenuates In Vitro and In Vivo Inflammatory Responses and Prolongs Survival in Murine Sepsis Models

被引:15
|
作者
Kopczynski, Michal [1 ]
Rumienczyk, Izabela [1 ]
Kulecka, Maria [1 ,2 ]
Statkiewicz, Malgorzata [1 ]
Pysniak, Kazimiera [1 ]
Sandowska-Markiewicz, Zuzanna [1 ]
Wojcik-Trechcinska, Urszula [1 ]
Goryca, Krzysztof [3 ]
Pyziak, Karolina [4 ]
Majewska, Eliza [4 ]
Masiejczyk, Magdalena [4 ]
Wojcik-Jaszczynska, Katarzyna [4 ]
Rzymski, Tomasz [4 ]
Bomsztyk, Karol [5 ]
Ostrowski, Jerzy [1 ,2 ]
Mikula, Michal [1 ]
机构
[1] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Genet, PL-02781 Warsaw, Poland
[2] Ctr Postgrad Med Educ, Dept Gastroenterol Hepatol & Clin Oncol, PL-01813 Warsaw, Poland
[3] Univ Warsaw, Ctr New Technol, Genom Core Facil, PL-02097 Warsaw, Poland
[4] Ryvu Therapeut SA, Biol R&D, PL-30394 Krakow, Poland
[5] Univ Washington, UW Med South Lake Union, Seattle, WA 98109 USA
基金
美国国家卫生研究院;
关键词
sepsis; drugs repurposing; ERK1/2; SCH772984; cecal ligation and puncture; READ ALIGNMENT; CECAL LIGATION; PATHWAY; TRANSCRIPTION; DEFINITIONS; DYSFUNCTION; DISRUPTION; DISCOVERY; ROLES; EGFR;
D O I
10.3390/ijms221910204
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sepsis is the leading cause of death in intensive care units worldwide. Current treatments of sepsis are largely supportive and clinical trials using specific pharmacotherapy for sepsis have failed to improve outcomes. Here, we used the lipopolysaccharide (LPS)-stimulated mouse RAW264.7 cell line and AlphaLisa assay for TNFa as a readout to perform a supervised drug repurposing screen for sepsis treatment with compounds targeting epigenetic enzymes, including kinases. We identified the SCH772984 compound, an extracellular signal-regulated kinase (ERK) 1/2 inhibitor, as an effective blocker of TNFa production in vitro. RNA-Seq of the SCH772984-treated RAW264.7 cells at 1, 4, and 24 h time points of LPS challenge followed by functional annotation of differentially expressed genes highlighted the suppression of cellular pathways related to the immune system. SCH772984 treatment improved survival in the LPS-induced lethal endotoxemia and cecal ligation and puncture (CLP) mouse models of sepsis, and reduced plasma levels of Ccl2/Mcp1. Functional analyses of RNA-seq datasets for kidney, lung, liver, and heart tissues from SCH772984-treated animals collected at 6 h and 12 h post-CLP revealed a significant downregulation of pathways related to the immune response and platelets activation but upregulation of the extracellular matrix organization and retinoic acid signaling pathways. Thus, this study defined transcriptome signatures of SCH772984 action in vitro and in vivo, an agent that has the potential to improve sepsis outcome.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] The inhibition of glycogen synthesis by fatty acids is not mediated by inhibition of extracellular signal-regulated kinase 1/2
    Smith, SR
    Lovejoy, JC
    DeLaney, JP
    Ruyter, I
    McNeil, M
    DIABETOLOGIA, 1999, 42 (08) : 1031 - 1032
  • [42] Monophosphothreonyl extracellular signal-regulated kinases 1 and 2 (ERK1/2) are formed endogenously in intact cardiac myocytes and are enzymically active
    Sugden, Peter H.
    Markou, Thomais
    Fuller, Stephen J.
    El Li Tham
    Molkentin, Jeffery D.
    Paterson, Hugh F.
    Clerk, Angela
    CELLULAR SIGNALLING, 2011, 23 (02) : 468 - 477
  • [43] Regulation of α2B-Adrenergic Receptor-mediated Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Activation by ADP-ribosylation Factor 1
    Dong, Chunmin
    Li, Chunman
    Wu, Guangyu
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (50) : 43361 - 43369
  • [44] Role of kinase suppressor of ras-1 in neuronal survival signaling by extracellular signal-regulated kinase 1/2
    Szatmari, Erzsebet
    Kalita, Katarzyna B.
    Kharebava, Giorgi
    Hetman, Michal
    JOURNAL OF NEUROSCIENCE, 2007, 27 (42): : 11389 - 11400
  • [45] Inhibition of extracellular signal-regulated kinase (ERK1/2) activity reverses endotoxin-induced hypotension via decreased nitric oxide production in rats
    Tunctan, B.
    Korkmaz, B.
    Dogruer, Z. N.
    Tamer, L.
    Atik, U.
    Buharalioglu, C. K.
    PHARMACOLOGICAL RESEARCH, 2007, 56 (01) : 56 - 64
  • [46] Reduction of chronic allograft nephropathy by inhibition of extracellular signal-regulated kinase 1 and 2 signaling
    Wang, Shuang
    Jiang, Jifu
    Guan, Qiunong
    Wang, Hao
    Nguan, Christopher Y. C.
    Jevnikar, Anthony M.
    Du, Caigan
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 295 (03) : F672 - F679
  • [47] Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites
    Rice, PL
    Goldberg, RJ
    Ray, EC
    Driggers, LJ
    Ahnen, DJ
    CANCER RESEARCH, 2001, 61 (04) : 1541 - 1547
  • [48] In vitro activation of extracellular signal-regulated kinase 1/2 in the inner ear of guinea pigs
    Hess, A
    Labbé, D
    Michel, O
    Teranishi, MA
    Orzechowska, O
    Schmidt, A
    Addicks, K
    Bloch, W
    BRAIN RESEARCH, 2002, 956 (02) : 236 - 245
  • [49] Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition
    Cea, Michele
    Cagnetta, Antonia
    Fulciniti, Mariateresa
    Tai, Yu-Tzu
    Hideshima, Teru
    Chauhan, Dharminder
    Roccaro, Aldo
    Sacco, Antonio
    Calimeri, Teresa
    Cottini, Francesca
    Jakubikova, Jana
    Kong, Sun-Young
    Patrone, Franco
    Nencioni, Alessio
    Gobbi, Marco
    Richardson, Paul
    Munshi, Nikhil
    Anderson, Kenneth C.
    BLOOD, 2012, 120 (17) : 3519 - 3529
  • [50] TARGETING NAD plus SALVAGE PATHWAY INDUCES AUTOPHAGY IN MULTIPLE MYELOMA CELLS VIA MTORC1 AND EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK1/2) INHIBITION
    Cea, M.
    Cagnetta, A.
    Fulciniti, M.
    Tai, Y. T.
    Chauhan, D.
    Hideshima, T.
    Roccaro, R.
    Nencioni, A.
    Gobbi, M.
    Patrone, P.
    Munshi, N.
    Anderson, K.
    HAEMATOLOGICA, 2012, 97 : 332 - 333